Beauty

Fine fragrance demand lifts Givaudan Q3 organic sales past forecasts

Givaudan's like-for-like sales rose 8.6% in Q3, nearly double analyst expectations, as premium perfumery and consumer fragrance categories both accelerated.

Ingrid LindqvistOctober 13, 20265 min read8 views

An abstract crystal perfume bottle on a marble surface with flowing scent ribbons and soft botanical leaves under warm golden light.

Givaudan's like-for-like sales grew 8.6% in the third quarter, almost double the 4.7% analysts had expected, as demand for luxury perfumes powered the fragrance and flavour group's beauty business.

Fragrance & Beauty drives the quarter

In the first nine months of the year, the Fragrance & Beauty division generated CHF 3.15 billion (US$3.78 billion), up 8.8% on a like-for-like (LFL) basis and ahead of the 8% growth recorded in the same period a year earlier. The unit accounted for roughly 53% of the company's overall sales during that window.

In the third quarter alone, Fragrance & Beauty sales reached CHF 1.14 billion (US$1.37 billion), with LFL growth of 13.5%, up from 6.8% in the third quarter of 2025. At group level, Givaudan recorded sales of CHF 5.89 billion (US$7.08 billion) over the first three quarters.

Fine fragrance and consumer products accelerate

Fine Fragrance sales increased 15.3% LFL, set against a competitive prior-year comparable of 18.7%. The company framed the back-to-back double-digit growth as evidence of continued resilience in its fine-fragrance business and strong demand across the premium perfume market.

Consumer Products sales rose 9.3% LFL against a prior-year comparable of 5.9%, which the company said shows fragrance demand extending into personal, oral, home and fabric care categories. By contrast, Fragrance Ingredients and Active Beauty combined fell 2.5%, compared with a 1.5% LFL increase in the first nine months of 2025.

Market and analyst reaction

Vontobel analyst Arben Hasanaj said the acceleration should reinforce confidence in Givaudan's growth profile and resilience, according to Reuters. Vontobel and Jefferies analysts also estimated that Fine Fragrance sales grew around 31% organically in the third quarter alone, Reuters reported.

The results lifted Givaudan's shares by nearly 7%, a 15-month high. Reuters reported that peers including dsm-firmenich, Novonesis and Symrise saw their shares rise between 1.6% and 3.1% in early trading after the update.

Currency, acquisitions and regional split

LFL figures exclude acquisitions. On a reported basis, acquisitions contributed 2.8% to Fragrance & Beauty growth during the nine-month period, while currency translation had a negative impact of 3.8%. At group level, acquisitions contributed 1.4%. Two transactions the company highlighted were the acquisitions of Belle Aire Creations for CHF 62 million (US$74.48 million) and Vollmens Fragrances for CHF 20 million (US$24 million).

Asia Pacific was Givaudan's fastest-growing geography, with sales up 10.6% LFL in the first nine months of 2026, compared with 4.6% a year earlier; within Taste & Wellbeing the region rose 7.1% LFL against a 0.5% LFL decline in the same period of 2025. South Asia, Africa and the Middle East increased 4.1% LFL, against 8.8% a year earlier. Europe rose 1.5% LFL versus 3.8%, and Latin America grew 1.1% LFL compared with 3.1%. High-growth markets advanced 7.9%, against more modest 2.7% growth in mature markets.

North America proved the most challenging region, with Taste & Wellbeing sales down 3.3% LFL, compared with a 3.9% increase in the first nine months of 2025, although the region overall grew 1.1%. Givaudan did not separate the region's figures by category. The company attributed the drop to continued weakness in its Health and Functional business unit and to US tariff refunds made to Givaudan customers during the third quarter of 2026.

Givaudan said the consistency of its growth despite geopolitical and macroeconomic volatility demonstrates market resilience, and its figures point to continued potential in fine fragrances, fragrance ingredient differentiation and premiumisation.